"Edge" across 2500 kilometers"
Release time:
2020-08-14
Crossing 2500 km "Edge"
■ Peak Health Wang Bingbing
In 2008 , I am about to graduate and face a major choice in my life-choosing a career. It was also at this time that the word "peak" entered my life. At that time, I was full of expectation and uneasiness. For a native northern girl, what will be waiting for me in this place 2500 kilometers away?
At the beginning of 2009 , I got on the south train alone and went through a journey of 48 hours to Jinhua, a southern city. I officially joined Jianfeng Pharmaceutical and became a QC in the Quality Control Department. I was 24 !
When I entered the laboratory, all my previous uneasiness disappeared, because this is a harmonious family with amiable teachers and vigorous friends. At the beginning, due to the language barrier, my colleagues tried their best to communicate in Mandarin in order to let me integrate into the group as soon as possible; the masters taught me various skills and experience hand in hand, which saved me a lot of detours and quickly completed it independently. Various inspection work. Jianfeng Pharmaceutical's production concept of "one bag, bottle, needle, one life" and the earnest teachings of the masters make me feel the responsibility on my shoulders as a quality manager.
During my time in the pharmaceutical industry, I also had an unexpected harvest, which was love. After Yin's general introduction, I got to know my husband and entered the palace of marriage in 2012 . I married directly from my "mother's family" and made the second major decision in my life. Since my husband belongs to the pharmaceutical development department, I have another "peak daughter-in-law" status.
In the 4 years and 4 months of Jianfeng Pharmaceutical, I have shed my youth and enriched myself through continuous efforts, laying the foundation for the future.
2013 7 May, I bid farewell to the "mentor" of Jianfeng Pharmaceutical and officially joined the preparation of Jianfeng Health. In the 5 years of peak health, I have challenged various positions, such as quality control, research and development, preparation of chain flagship stores, academic training, sales key account management, market management, etc. I have experienced every innovation and development of peak health. Recalling the past five years, there have been countless "firsts", the first time to open a store (chain flagship store preparation), the first time to switch (transferred to the marketing department), the first lecture (community training), the first time to face sales (sales of key account management)... It is these "firsts" that have built up the steps of my career. Of course, the most difficult one was that...
In 2015 , Jianfeng Health won the right to host the "Ninth Forum on Innovation and Development of Chinese Herbal Pieces and the Symposium on International Business Standards of Chinese Herbal Pieces. Originally, it was planned that the main venue would be located in Hangzhou and a professional conference team would be hired to take the exercise. However, due to various reasons, the main venue was finally set in Jinhua, and the task fell gloriously to my then partner Xu Yuting and me. In two months, we have to arrange the agenda of the meeting, sponsor, invite speeches and guests to attend the meeting, and for a high-level seminar like this, the guests must also be well-known experts and elites in the industry. For the newcomers, it is almost impossible to complete the task with no experience and resources.
The most difficult thing is to invite guests to the conference. Because they have no resources on hand, they can only go to the websites of relevant enterprises to inquire about the contact information. However, when they call, they are often regarded as swindlers and do not want to pay attention to them. Through the introduction of teachers and classmates and the recommendation of peers, we finally won the trust of some people in the industry, the popularity of Jianfeng Health has also increased, and many enterprises have taken the initiative to come to the door to sign up for the meeting. When the meeting was finally held, Ren Daquan, former deputy director of the State Food and Drug Administration, 15 experts and professors in the industry, and more than 100 well-known entrepreneurs in the field of Chinese herbal pieces came to attend, which not only achieved a complete success, but also was highly valued by the Jinhua Municipal Government. Therefore, I was promoted to the head of the marketing department, which really started my marketing career.
In recent years, the marketing department has carried out many reforms according to the strategic adjustment of peak health, trying chain stores, e-commerce, sales, new micro-commerce and other modes, and the publicity method has also evolved from traditional paper media advertising to outdoor, car body, network and other emerging media. 2017 , we also tried to buy TV shopping, opened Jinhua terminal market, and launched large-scale push activities such as "Jianfeng Walking, Bone Tailai Refueling" and "Jianfeng Bone Tai Free Clinic Community Tour. 2018 , in order to further promote the new micro-business model, the marketing department also organized the development of 6 functional foods suitable for the promotion of new micro-business. With the development of Jianfeng Group, Jianfeng Health is also making unremitting efforts and constantly trying to move forward courageously. I am also constantly looking for myself in it.
2018 is the 73rd anniversary of peak venture 60#. I am honored to witness this moment and am grateful to be able to walk through the best 10 years of my life hand in hand with peak. I believe that with the joint efforts of all the peak staff, the peak career can flourish and create greater brilliance!
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31